http://rdf.ncbi.nlm.nih.gov/pubchem/patent/PL-378995-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f59202851a91ab0cb6309f22197d1af9
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N25-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01P13-00
filingDate 2006-02-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3758b7a4308f9147aa9e757a17d79400
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_af5863eba5b5e0a23587aea7ee71379b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9c11e7e16b45cbb28d0dbff0ead302c6
publicationDate 2007-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber PL-378995-A1
titleOfInvention The use of anisole as an inhibitor of clomazone crystallization in microcapsules or microparticles
priorityDate 2006-02-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425413332
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419520438
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8108
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54778
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419525513
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7519

Total number of triples: 19.